Moderna rises after $6 million in insider purchases revealed
Moderna’s share price is spiking after the company disclosed early Wednesday that CEO Stephane Bancel and Board Director Paul Sagan have purchased $6 million worth of the company’s stock.
According to the filings, Bancel acquired 160,314 shares for a total of $5 million, while Sagan bought 31,620 shares for $1 million. The executives purchased the shares at about $31 per share.
Moderna shares have fallen more than 20% since the start of the year. The vaccine maker has struggled to keep up with investor expectations after its Covid vaccine revenue dried up. Moderna did receive money from the government to develop a bird flu vaccine, which excited investors, though that grant is reportedly being reevaluated.